Search Results for keywords:"misbranded drug"

Found 1 results
Skip to main content

Search Results: keywords:"misbranded drug"

  • Type:Notice
    Citation:89 FR 96655
    Reading Time:about 13 minutes

    The Food and Drug Administration (FDA) has decided to deny Yong Sheng Jiao's request for a hearing and issued a final debarment order. Jiao, who pleaded guilty to felony charges related to importing a misbranded drug into the U.S., is barred for five years from providing services connected to drug application processes. The FDA determined that the seriousness of Jiao's offense warranted this punishment, despite Jiao's claims of misunderstanding and attempts to challenge the penalty's severity. The decision reflects the FDA's commitment to maintaining the safety and integrity of the drug industry in the United States.

    Simple Explanation

    The FDA told Yong Sheng Jiao he can't work with companies that make drugs for five years because he did something wrong with bringing medicine into the country. He wanted to explain his side, but he didn't give enough information to change their decision.